基本信息
views: 760
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Feng’s clinical interests include the diagnosis and management of genitourinary malignancies. He specializes in the treatment of high-risk aggressive prostate cancers as well as oligometastatic disease. For upfront or post-surgical treatment for patients, his therapeutic approaches include intensity-modulated radiation therapy as well as stereotactic ablative radiotherapy, among many others. Dr. Feng is nationally known for his approaches of using molecular biomarkers to help guide or personalize radiation therapy for patients. He serves as the leader of the Genitouirnary Cancer Translational Research Program for the NRG Clinical Trials Group, and is a member of the National Cancer Institute Steering Committee for Genitourinary Cancers. He has helped conduct numerous clinical trials, and is the co-principal investigator of one of the first biomarker-driven clinical trials for patients with metastatic prostate cancer.
Research Interests
Papers共 1024 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Advances in radiation oncologyno. 7 (2024): 101507-101507
Osama Mohamad, Yun Rose Li,Felix Feng,Julian C Hong,Anthony Wong, Zakaria El Kouzi, Mohamed Shelan,Thomas Zilli,Peter Carroll,Mack Roach
Prostate cancer and prostatic diseasespp.1-8, (2024)
crossref(2024)
Journal of Clinical Oncologyno. 16_suppl (2024): 101-101
crossref(2024)
European Urologyno. 2 (2024): 81-87
European Urology (2024)
Nature geneticsno. 8 (2024): 1689-1700
European urology focusno. 2 (2024): 271-278
Zenghua Fan,David Y. Oh,Anthony Wong,Katsuto Shinohara,Hao Nguyen, Caleb Hwang,Hewitt Chang,Alec Starzinski,Tony Li, Christopher De Leon, Marissa Gin,Eliezer Van Allen,
Cancer Researchno. 6_Supplement (2024): 4988-4988
Load More
Author Statistics
#Papers: 990
#Citation: 37973
H-Index: 89
G-Index: 184
Sociability: 9
Diversity: 3
Activity: 427
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn